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Abstract
The active release of pharmaceutical agents and the use of porous sensor membranes represent the
two most promising strategies for addressing the poor tissue biocompatibility of implantable
glucose biosensors. Herein, we describe the combination of these approaches to create nitric oxide
(NO)-releasing porous fiber mat-modified sensor membranes. An electrospinning method was
used to directly modify needle-type glucose biosensors with the NO donor-loaded fibers. The
resulting NO-releasing fiber mat (540 ± 139 nm fiber diameter, 94.1 ± 3.7% porosity) released
~100 nmol NO per mg polyurethane over 6 h while maintaining a porous structure without
leaching of the NO donor, even in serum. The porous fiber membrane did not influence the
analytical performance of the biosensor when ≤ 50 μm thick.
Introduction
Percutaneously implanted electrochemical biosensors for continuous glucose monitoring
(CGM) hold great potential for reducing complications of diabetes due to their ability to
warn of hyperglycemia or hypoglycemia events.1, 2 Limitations such as short sensor life (≤1
week), the need for frequent calibration (2–4 times/day), and unreliable accuracy in the data
provided have prevented wide spread use of such devices to date.1, 3, 4 Most shortcomings of
CGM systems are due to the foreign body response (FBR).5 Inflammatory cell response and
collagen capsule formation, and the risk of infection due to percutaneous implantation result
in poor analytical performance in vivo.2 Recent work has focused on the development of
outer membranes to mitigate the FBR and improve tissue integration and in vivo sensor
performance.2, 6
Nitric oxide (NO)—an endogenously produced diatomic free radical—plays a number of
physiological roles (e.g., angiogenesis, wound healing, and vasodilation) depending on
release location and concentration.7, 8 To utilize NO as a pharmaceutical agent, we and
others have developed macromolecular NO-release scaffolds using N-diazeniumdiolate or S-
nitrosothiol NO donors that enable controlled NO release.8, 9 As biomaterials, NO-releasing
interfaces have been shown to decrease the adhesion of inflammatory cell, reduce collagen
capsule thickness, and increase blood vessel formation near the biomaterial.10, 11
Additionally, the NO-releasing surfaces have proven to be highly effective at reducing
bacteria adhesion, eradicating biofilms, and decreasing implant-associated infections.12–15
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Release of NO from glucose sensor membranes has been studied as an active strategy to
mitigate the FBR and thus improve sensor performance in vivo by addressing the greatest
shortcoming of such devices.16 Nitric oxide release has been imparted to glucose sensors
membranes by patterning NO-releasing xerogel array on top of a membrane17 or physically
entrapping NO donors (e.g., NO-releasing silica particles18, 19 or low molecular weight
molecules20) within polyurethane (PU) sensor membranes. Such NO-releasing membranes
exhibited adequate analyte diffusion without compromising sensor performance.18, 19
Gifford et al. reported that NO fluxes >0.83 pmol cm−2 s−1 for 18 h from a needle-type
glucose biosensors were sufficient to reduce inflammation and enhance the sensor accuracy
at 24 h post implantation compared to control sensors in a rodent model.20
Surface modifications based on porous architectures have also been developed and represent
a passive strategy for improving tissue integration and decreasing collagen capsule
formation.21–24 Electrospun fibers appear promising as glucose sensor membranes because
of their high surface to volume ratio and superior mechanical properties.25 Additionally,
electrospun fibers are able to be directly coated onto electrodes without impeding glucose
oxidase activity since the polymer fibers solidify as the solvent evaporates during the
electrospinning process.26 Random oriented fibers with submicron diameter (~0.6 μm) have
been reported to be effective at reducing secretion of proinflammatory molecules,
decreasing the adhesion of foreign body giant cells, and promoting cell migration and
proliferation—all resulting in reduced capsule formation.25, 27–29 Wang et al. recently
reported coating PU electrospun fibers on implantable glucose sensors using a dynamic
collector, highlighting the ability to modify microsensors with porous membranes.26 While
electrospun fibers allow for the encapsulation and release of therapeutics in a controlled
manner,27, 30, 31 the use of drug-releasing electrospun fibers for implantable glucose sensors
has not yet been reported.
Herein, we report the design of NO-releasing dendrimer-doped electrospun PU fibers as
porous outermost glucose sensor membranes as depicted in Figure 1. The characterizations
of needle-type glucose biosensors fabricated using such interfaces were demonstrated the
ability to combine both active (i.e., NO-release) and passive (i.e., porous) strategies within a
single outer sensor membrane coating.
Experimental
Materials
Glucose oxidase (type VII from Aspergillus niger), D-glucose anhydrous, acetaminophen
(AP), L-ascorbic acid (AA), and uric acid (UA) were purchased from Sigma (St. Louis,
MO). All salts and organic solvents were laboratory grade and purchased from Fisher
Scientific (St. Louis, MO). Methyltrimethoxysilane (MTMOS) and phenol were purchased
from Fluka (Buchs, Switzerland). Tecophilic (HP-93A-100) and Tecoflex (SG-85A)
polyurethanes were gifts from Thermedics (Woburn, MA). Hydrothane (AL 25–80A)
polyurethane was a gift from AdvanSource Biomaterials Corporation (Willmington, MA).
Tecoplast (TP-470) polyurethane was a gift from Lubrizol (Cleveland, OH). Stainless steel
wire (316L, 381μm diameter) was purchased from McMaster-Carr (Atlanta, GA).
Polyterafluoroethylene (PTFE) coated-Pt/Ir (90% Pt) wire (177.8 and 246.4 μm bare and
coated diameter, respectively) and silver wire (Ag 99.99%, 127 μm diameter) were
purchased from Sigmund Cohn Corp. (Mount Vernon, NY). Nitrogen, argon, and nitric
oxide calibration gases were purchased from Airgas National Welders Supply (Durham,
NC). Anticoagulated whole blood with 5 U/mL heparin was obtained from healthy pigs at
the Francis Owen Blood Research Laboratory (Chapel Hill, NC). Serum was obtained from
this sample by centrifuging the blood for 15 min under 2000 ×g at 4 °C. Water was purified
Koh et al. Page 2













(18.2 MΩ·cm; total organic content <6 ppb) using a Millipore Milli-Q Gradient A-10
purification system (Bedford, MA).
Nitric oxide-releasing dendrimer-doped polyurethane solution
1,2-Epoxy-9-decene (ED) functionalized fourth-generation of poly(amidoamine) (PAMAM)
dendrimers (PAMAM G4-ED/NO) were synthesized as previously reported.32 Subsequent
N-diazeniumdiolation of the PAMAM G4-ED was performed as described previously.32, 33
N-diazeniumdiolation of the 1,2-epoxy-9-decene (ED) functionalized fourth-generation
poly(amidoamine) (PAMAM) dendrimers (PAMAM G4-ED) was performed under high
pressure of NO (10 atm) for 3 d in the presence of sodium methoxide at room temperature
with constant stirring. The NO donor-modified dendrimers were then stored in a methanol
solution with sodium methoxide at −20 °C until use. The NO-release properties of the
dendrimers and dendrimer-doped polyurethane electrospun fiber mat were then evaluated
using both chemiluminescence and Griess assay. Nitric oxide release was measured using a
Sievers Chemiluminescence Nitric Oxide Analyzer (NOA) Model 280i (Boulder, CO). To
determine NO flux, electrospun samples were placed in a solution of deoxygenated PBS
(0.01 M, pH 7.4) at 37 °C. The NO was carried to the NOA instrument by a stream of N2
gas at a controlled rate (200 mL min−1 instrument collection rate). The NOA was calibrated
using a 26.80 ppm NO gas (balance N2) and air passed through a Sievers NO zero filter.
Total amounts of NO released were determined indirectly by measuring the nitrite
concentration via the Griess assay using a Labsystem Multiskan RC Microplate
Spectrophotometer (at 540 nm; Helsinki, Finland). Of note, total NO concentrations
measured with the Griess assay agreed with those obtained from chemiluminescence
analysis indicating that these materials released NO and not nitrite.
Fabrication of needle-type glucose sensors
Needle-type glucose sensors were fabricated by adapting a procedure described
previously.20, 34–36 A silver/silver chloride (Ag/AgCl) wire electrode was fabricated by
winding silver (Ag) wire on stainless steel wire (2.5 cm length). The wire was converted to
AgCl via galvanometry by soaking in saturated ferric chloride (FeCl3) solution for >2 h.
After sonication in water and ethanol for 15 min each, the Ag/AgCl wire was removed from
the stainless steel and wrapped around a polytetrafluoroethylene (PTFE)-coated Pt/Ir wire
(3.5 cm length). A section of the PTFE coating (~5 mm) was then stripped from the end of
wire to expose the sensing cavity. The end of the sensor was sealed with epoxy, resulting in
a ~2 mm sensing cavity (surface area ~0.017 cm2). As shown in Figure 1, the sensing cavity
consisted of four functional layers: (1) an inner-selective membrane, that excludes
electroactive interferents such as ascorbic acid (AA), uric acid (UA), and acetaminophen
(AP); (2) a glucose oxidase layer, where glucose is converted to gluconolactone and oxygen
to hydrogen peroxide; (3) a diffusion limiting layer that controls the diffusion and
partitioning of glucose and oxygen to overcome the oxygen deficit in vivo; and, (4) a porous
NO-releasing electrospun fibrous membrane designed to mitigate the FBR. The inner-
selective polyphenol layer was applied under control of self-limiting electropolymerization
(film thickness of ~10–100 nm) to prevent interfering species from reaching or fouling the
electrode surface, affording a great improvement in biosensor selectivity over
acetaminophen in particular (see SI Figure 4). The electrochemical polymerization of the
permselective polyphenol films was carried out potentiostatically at +900 mV (vs. Ag/AgCl)
for 15 min in 40 mM phenol solution in phosphate buffered saline (PBS, pH 7.4) after
degassing with nitrogen for 20 min. The charge passed during electropolymerization was
−0.53 ± 0.27 μC. A glucose oxidase (GOx) layer was then applied on top of the inner-
selective membrane by immobilizing GOx within a sol-gel matrix. The enzyme-containing
sol was prepared as described previously.18, 19 The needle-type electrodes were dip-coated
15 times (with a single cycle consisting of a 5 s dip with 10 s drying under ambient
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conditions). The enzyme layer contained an excess of glucose oxidase so that the rate of
glucose conversion was only dependent on glucose concentration. The diffusion-limiting
layer was added by dip-coating the electrodes twice in a polyurethane (PU) polymer solution
consisting of 80 mg mL−1 50% (w/w) Tecoflex and Hydrothane dissolved in 50% (v/v)
THF/EtOH solution. Each layer was dried under ambient conditions for 30 min before
casting the subsequent layer. The thickness of the diffusion-limiting PU layer was 28.2 ±
13.0 μm, allowing for a dynamic glucose response range over the entire physiological range
of blood glucose concentrations (1–30 mM). The outermost NO-releasing electrospun
porous polyurethane membranes were coated onto the needle-type glucose sensors using a
custom electrospinning apparatus consisting of a Series 205B High Voltage Power Supply
(Bertan Associates, Inc.; Hicksville, NY), a Kent Scientific Genie Plus syringe pump
(Torrington, CT), and a rotating collector.31 A schematic of the set-up and the
electrospinning parameters employed are provided in Supporting Information (SI Figure 1
and SI Table 1). Polyurethane solutions containing NO-releasing dendrimers were prepared
by first dissolving the PU in 1.6 mL of a 3:1 (v/v) tetrahydrofuran (THF):N,N-
dimethylformanide (DMF) mixture, followed by the addition of PAMAM G4-ED/NO
solution (400 μL dissolved in methanol). The final concentration of polymer in solution was
12–16% (w/v). Dendrimer concentration is reported as wt% of the polymer mass.
Electrochemical sensor performance
The analytical performance of the fabricated glucose biosensor was electrochemically
evaluated via constant potential amperometry using a CH Instruments 1030A potentiostat
(Austin, TX). Sensor performance was evaluated in 0.01 M PBS (pH 7.4) or porcine serum
at room temperature or 37 °C using an integrated Ag/AgCl wire as a pseudo counter and
reference electrode. After the background current was polarized, the sensitivity, response
time, and selectivity of the biosensors were evaluated by sequentially injecting aliquots of
glucose or interferent solutions into PBS or serum with constant stirring. A working
electrode potential of +600 mV vs. Ag/AgCl was employed. This applied potential allows
adequate glucose sensitivity and minimal current interference from NO oxidation (+900 mV
vs. Ag/AgCl).18 The sensitivity to glucose was determined based on the slope of the linear
regression between the measured oxidation current and glucose concentration. The
amperometric selectivity coefficient ( ) was calculated according to equation (1)
where ΔIglu and ΔIj are the changes in measured current responses to predetermined
concentrations of glucose (cglu) and interference species (cj; j=AP, AA, and UA),
respectively.
(1)
Characterization of NO-releasing dendrimer-doped electrospun fiber membrane-coated
needle-type glucose sensors
Fiber diameter and percent porosity were determined using an environmental scanning
electron microscope (ESEM; Quanta 200 field emission gun; FEI company; Hillsboro, OR)
without additional metal coating. Fiber diameters were determined using NIH ImageJ
software (Bethesda, MD). The percent porosity of the fibrous membrane was calculated
according to the following equation where ρ is the density of the electrospun fiber mats, and
ρ0 is the density of the bulk polymer.23, 37, 38
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Nitric oxide release from the fabricated electrospun fiber mat was evaluated as described
above.31, 39 The stability and distribution of the dendrimers within the PU fibers was
assessed using fluorometry and confocal microscopy.33 Before modifying the PAMAM
dendrimers with ED functional groups, dendrimers were tagged with rhodamine
isothiocyanate (RITC) in a 1:1 molar ratio so that on average only one of the 64 primary
amines on the dendrimer surface was modified. After fluorescently labeled dendrimer-doped
fiber membranes were incubated in PBS for 7 d at 37 °C, the fluorescence of the soak
solution was measured using Cary Eclipse fluorescence spectrometer (Varian Inc., Palo
Alto, CA). The fluorescence intensity represented the degree of dendrimer leaching. In
addition to this stability test, confocal fluorescence microscopy was used to image the
distribution of fluorescently labeled PAMAM G4-ED/NO dendrimer in the electrospun
fibers with an LSM 510 laser scanning confocal microscope (Carl Zeiss, Thornwood, NY).
Results and Discussion
Characterization of NO-releasing dendrimer-doped electrospun polyurethane fibers
Non-porous PU membranes have been employed to fabricate implantable glucose sensors in
order to balance the diffusion ratio of glucose and oxygen, and prevent an oxygen
deficit.20, 40, 41 Generally, such polymers are also considered tolerable by the body.
Nevertheless, the immune response and subsequent collagen encapsulation that forms
around the sensor and PU membrane still negatively impacts in vivo glucose sensor
performance.42 To potentially reduce the foreign body response (FBR) and improve the
analytical performance of CGM sensors,2, 6 NO donor-containing PU fibers were
electrospun onto enzyme-based needle-type glucose sensors as an additional outermost
porous membrane on top of the standard diffusion-limiting PU layer to create a porous
interface capable of releasing a therapeutic agent known to mitigate the FBR (Figure 1).
Prior to bench top sensor testing, the N-diazeniumdiolated dendrimer-doped electrospun
fibrous PU membranes were characterized with respect to their physical properties (e.g.,
fiber diameter and porosity), NO release, and stability (i.e., dendrimer leaching). Scanning
electrochemical microscopy imaging of the cross section of the fully fabricated glucose
sensor confirmed a tree dimensional outer membrane, highlighting the ability to successfully
coat porous electrospun fibers onto needle-type biosensors (Figure 2B). As shown in Figure
2, the electrospun membranes exhibited a random open pore structure with interconnected
fibers and no bead formation over the entire electrode surface (1.4 ± 0.7 mg/sensor). Water
uptake by the fibers, important for both glucose response and NO release, varied based on
the type of PU (4.7 ± 1.0, 1.6 ± 0.2, and 0.8 ± 0.5 mg of water/mg of PU fiber for
Tecophilic, Tecoflex and Tecoplast, respectively). Fiber diameters ranging from 400–600
nm were achieved by varying the concentration of PU solution (12–16% (w/v)). Of note,
such diameters were previously shown to reduce both the adhesion and activation of
macrophage cells, suggesting a lessened initial FBR.28 The presence of the NO donor-
modified dendrimer did not significantly affect fiber diameter. The percent porosity of the
fibrous membranes for fiber diameters ranging from 400–600 nm was 67.3 ± 4.4, 57.6 ± 2.5,
and 94.1 ± 3.7 % for the Tecophilic, Tecoflex, and Tecoplast fibers, respectively. Such
porosity is in line with prior reports describing the use of highly porous interfaces (>90%
porosity) to increase cell infiltration and reduce collagen capsule formation (i.e.,
thickness).23, 29 Based on the above data and the prior tissue biocompatibility literature, the
Tecoplast fiber mat would likely be most effective at reducing the FBR.
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Nitric oxide release from PAMAM G4-ED/NO dendrimer-doped electrospun fiber
membranes was measured in PBS (pH 7.4) at 37 °C to mimic physiological conditions (SI
Figure 2). The Tecoplast electrospun fiber membrane doped with 5 wt% PAMAM G4-ED/
NO dendrimer exhibited a maximum NO flux of 19.8 ± 6.4 pmol mg−1 s−1 with 0.10 ± 0.08
μmol mg−1 total NO released over ~7 h. The time to reach maximum NO flux was 2.2 ± 0.3
min. As expected, the total NO released was proportional to the amount of dendrimer
embedded within the fibers. For example, the total amount of NO released from the
Tecoplast PU fibers was increased from 0.10 ± 0.08 to 0.27 ± 0.12 μmol mg−1 upon altering
the NO donor (PAMAM G4-ED/NO) concentration from 5 to 10 wt%. Surprisingly, the NO
release (kinetics) was not altered based on water uptake by the PU. Although the use of
more hydrophobic PU (i.e., Tecoplast) resulted in a slightly suppressed maximum NO flux,
the duration of NO release was similar to the NO-releasing dendrimer alone (Table 1). Such
behavior is attributed to the porous structure of the electrospun fiber mat and/or the
distribution of dendrimers within the fibers.31 Although the duration of release was not
significantly extended in this case, co-axial electrospun fibers consisting of an NO-releasing
core and distinct water-restricting hydrophobic polymer sheath may further extend the NO-
release duration. Such studies are currently in progress. Based on the most ideal fiber
characteristics (i.e., diameter, porosity, and NO release), Tecoplast was chosen as the
polymer system for studies demonstrating the ability to directly modify already fabricated
glucose biosensors with a porous outer membrane.
Rhodamine isothiocyante (RITC) fluorophore-tagged dendrimers were used to evaluate the
distribution and stability of NO donor. Confocal microscopy confirmed that the fluorescent
NO-releasing PAMAM G4-ED dendrimers were homogeneously dispersed within
individual fibers (Figure 2D) and throughout the entire fiber mat. Stability of the NO-
releasing dendrimer within the fibers was determined using a leaching assay. Fibers doped
with fluorescently modified dendrimers were immersed in PBS (pH 7.4 at 37 °C) for 7 d.
Fluorescence emission (at 570 nm) of the soak solution was then measured using the
fluorometer. These soak solutions did not fluorescence indicating that the leaching
concentrations were less than the limit of detection (i.e., 0.03 μg/mL). Indeed, leaching of
the dendrimer NO-release vehicles from the fibers were negligible (<0.5%).
To assess the structured stability of the three-dimensional porous membranes, the
electrospun fiber-coated glucose biosensors were soaked in PBS and porcine serum for 7 d
at 37 °C. The Tecoplast electrospun fiber membrane (characterized by the lowest water
uptake) maintained its porous structure after soaking in PBS for >7 d. In contrast, the
Tecophilic membrane (highest water uptake) exhibited reduced porosity due presumably to
the swelling of the fibers (data not shown). The topography of the Tecoplast electrospun
fiber mat-modified sensor was constant even after 1 week incubation in porcine serum (SI
Figure 3). Of note, the structural stability of the porous membranes suggests the potential for
in vivo use.43
Electrochemical performance of electrospun membrane coated glucose biosensor
The analytical response of the fabricated NO-releasing electrospun fiber-modified needle-
type glucose sensors was characterized in vitro as a function of PU composition to assess the
impact of the fiber mat (Table 1). Neither the electrospinning process nor NO release
affected the sensor performance. Sensor response was studied as a function of the
electrospun membrane thickness using the most hydrophobic PU (i.e., Tecoplast). Adjusting
the feed volume of the polymer solution during the electrospinning process allowed us to
vary the fiber mat thickness. Greater feed volumes resulted in thicker fiber mats (44.5 ±
12.2, 71.5 ± 19.1, and 241.5 ± 84.3 μm for 1, 2, and 3 mL, respectively) that were no longer
useful as sensor membranes (Figure 3). While the addition of ≤50 μm thick electrospun fiber
outer membranes enables both a rapid glucose response (~1 min response time; t95%) and
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suitable dynamic range, thicker (>50 μm) fiber mat membranes exhibited response similar to
non-porous hydrophobic PU sensor membranes (t95%= ~125–250 s). Subsequent sensor
performance testing was thus carried out using biosensors fabricated with thin (~45 μm)
electrospun fiber mat membranes.
Glucose sensor performance was also evaluated as a function of PU fiber composition and
water uptake. Regardless of PU fiber composition, the dynamic response range of all sensors
was 1–30 mM glucose as would be expected due to the diffusion-limiting non-porous PU
membrane layer beneath the porous fiber mat. This diffusion-limiting layer also dictated the
glucose sensitivity of the biosensors. The use of a lower water uptake PU (i.e., Tecoplast)
fiber mat as the outermost porous membrane resulted in decreased sensor response to
glucose and a longer response time (Table 1). While Tecophilic PU had a negligible effect
on sensitivity and response time, the more hydrophobic PU (i.e., Tecoplast) reduced sensor
response to glucose by ~30% while increasing response time (t95%) from 15.9 ± 9.0 to 76.4
± 21.7 s. Of note, the addition of the more hydrophobic porous membrane neither
compromised the selectivity nor dynamic range.
Despite the diminished sensor performance, the sensitivity of the resulting glucose biosensor
coated with the dendrimer-doped Tecoplast electrospun fiber (16% (w/v) with 5 wt%
PAMAM G4-ED/NO dendrimer) was 2.4 ± 1.6 nA/mM (Figure 4), a response comparable
to commercially available and previously published implantable glucose biosensors.40, 44
The amperometric selectivity coefficients of the biosensors were −0.73 ± 0.85, 0.96 ± 0.10,
and 0.28 ± 0.14 for ascorbic acid, acetaminophen, and uric acid, respectively, indicating that
the fiber mat-modified biosensors were sufficiently selective for glucose over interferences
at physiologically relevant concentrations. To mimic a more physiologically relevant
solution, the sensor response was also evaluated in porcine serum at 37 °C, resulting in
sensitivity of 2.15 ± 0.60 nA/mM. In addition to a comparable sensitivity to the PBS studies
above, the biosensors remained functional for at least a week in serum at 37 °C (data not
shown). While bench-top evaluation of the sensor performance suggests a viable device,
additional in vivo experiments are obviously necessary to understand the benefits of porosity
and NO release on analytical performance. Planning of such studies is currently underway.
Conclusion
Porous fiber mats capable of NO release may reduce the undesirable FBR associated with
sensor implantation in subcutaneous tissue. Herein, a facile electrospinning method was
developed to modify needle-type electrochemical biosensors with thin, NO-releasing porous
PU membranes. Importantly, sensor performance was not diminished with the additional
NO-releasing membrane, suggesting similar fibrous coatings could be applied to other
tissue-contacting devices with minimal impact to device utility.
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Schematic of the layer-by-layer structure of NO-releasing porous electrospun fiber
membrane coated needle-type glucose sensors with actual fabricated electrode shown on the
right.
Koh et al. Page 10














Environmental scanning electron microscope (ESEM) images of (A) the surface of the NO-
releasing dendrimer-doped electrospun polyurethane membrane-modified needle-type
glucose sensors; with (B) cross-sectional view indicating (i) sol-gel/glucose oxidase enzyme
layer, (ii) the diffusion-limiting non-porous polyurethane layer, and (iii) the electrospun
fiber porous membrane (mat); (C) higher magnification view of the electrospun fiber mat
with inset indicating fiber diameter size distribution (540 ± 139 nm); and (D) confocal
image of a single fiber containing RITC-labeled dendrimer.
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Amperometric response of needle-type glucose sensors coated with NO-releasing dendrimer
(PAMAM G4-ED/NO)-doped membranes at a fiber mat thickness of (i) 45 to (ii) 72 and (iii)
242 μm. The glucose concentration was changed at 3 mM increments.
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(A) Amperometric response of a needle-type glucose sensor for (i) control (i.e., without) and
(ii) 5 wt% NO-releasing dendrimer-doped 16% (w/v) Tecoplast electrospun fiber-modified
outermost membrane. Glucose, ascorbic acid (AA), acetaminophen (AP), and uric acid (UA)
were sequentially injected at relevant in vivo concentrations. (B) Calibration curves of (i)
control and (ii) porous electrospun fiber membrane-modified glucose sensors in pH 7.4 PBS.
The applied electrode potential was +600 mV vs. Ag/AgCl.
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Table 1
Characterization of NO release and glucose sensor performance for the porous NO-releasing electrospun fiber-
modified needle-type glucose sensors as a function of the fiber. All porous membranes were doped with 5 wt
% N-diazeniumdiolated dendrimers (PAMAM G4-ED/NO).
Type of polyurethanea Tecophilic (HP-93A-100) Tecoflex (SG-80A) Tecoplast (TP-470)
PU solution concentrationb (% (w/v)) 12 12 16
Physical properties of
outermost membrane
Water uptake (mg, H2O/mg,
Fiber mat)
4.7 ± 1.0 1.6 ± 0.2 0.8 ± 0.5
Percent porosity (%) 67.3 ± 4.4 57.6 ± 2.5 94.1 ± 3.7
Fiber diameter (nm) 567 ± 288 404 ± 190 540 ± 139
Sensor performance
Glucose Sensitivity (nA mM−1) 4.1 ± 3.8 3.0 ± 2.0 2.4 ± 1.6
Response time (t95%; s) 32.1 ± 7.2 43.3 ± 12.7 76.4 ± 21.7
NO release properties
[NO]max (pmol mg−1s−1) 52.0 ± 26.1 24.4 ± 8.2 19.8 ± 6.4
Total NO releasedc (μmol mg−1) 0.15 ± 0.02 0.14 ± 0.03 0.10 ± 0.01
td (h)d 7.3 ± 3.6 8.9 ± 1.6 6.7 ± 1.0
a
The water uptake of polyurethanes was described previously.18
b
Concentration of polymer solution was optimized to achieve 400–600 nm fiber.28
c
Total NO released as determined using the Griess assay.
d
Experimentally defined at time point of 99% NO released.
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